Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy
- PMID: 29801053
- DOI: 10.1001/jamapediatrics.2018.0772
Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy
Comment in
-
Cost-effectiveness of Nusinersen for Spinal Muscular Atrophy-Reply.JAMA Pediatr. 2018 Jul 1;172(7):701-702. doi: 10.1001/jamapediatrics.2018.0733. JAMA Pediatr. 2018. PMID: 29800980 No abstract available.
Comment on
-
Nusinersen for Spinal Muscular Atrophy: Are We Paying Too Much for Too Little?JAMA Pediatr. 2018 Feb 1;172(2):123-125. doi: 10.1001/jamapediatrics.2017.4360. JAMA Pediatr. 2018. PMID: 29228077 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical